The trajectory of fatigue over time in breast cancer patients treated with chemotherapy: exploring the effect of anthracycline-based chemotherapy
These observations suggest that (neo)adjuvant anthracycline-based chemotherapy in breast cancer patients is associated with higher levels of fatigue during treatment as well as a prolonged burden of fatigue. Treatment tailored fatigue management strategies may be particularly useful for patients undergoing anthracycline-based chemotherapy.
Authors
- Hans A. J. Gelderblom (ORCID: https://orcid.org/0000-0001-9270-8636)
- Claudia A. Bargon (ORCID: https://orcid.org/0000-0002-5558-1530)
- Laura Kervezee (ORCID: https://orcid.org/0000-0002-6062-9164)
- Anneke Kastelein (ORCID: https://orcid.org/0000-0002-9099-5050)
- Jacques Neefjes (ORCID: https://orcid.org/0000-0001-6763-2211)
- Daniel J. Evers (ORCID: https://orcid.org/0009-0007-9973-0618)
- N.H. Chavannes
- Anne M. May
- Annemiek Doeksen
- Carmen C. van der Pol
- Helena M. Verkooijen
Institutions
- Utrecht University (NL)
- Leiden University Medical Center (NL)
- University Medical Center Utrecht (NL)
- Alrijne Ziekenhuis (NL)
- St. Antonius Ziekenhuis (NL)
- Oncode Institute (NL)
- Ziekenhuis Groep Twente (NL)
Publication Details
- Journal
- The Breast
- Published
- 2026-01-14
- DOI
- https://doi.org/10.1016/j.breast.2026.104700
- Citations
- 1
- Primary Topic
- Cancer survivorship and care
- Type
- article
- Field-Weighted Citation Impact
- 24.20